Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients.
      Google Scholar   
Citation:
Cancer
Year:
2020
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
SDC:
No
Book Volume:
Parents:
2948  
Children:
None
Program:
CCP
Primary Committee:
Health Outcome
Sec. Committees:
Symptom Inter    
Pharmas:
 
Grants:
UG1CA189823, UG1CA189860, UG1CA189817, UG1CA189819, U10CA180790, U10CA180836, U10CA180850, P30CA033572, UL1TR001409  
Corr. Author:
 
Authors:
                                 
Networks:
ADM400, ADM403, ALLIANCE, CA043, CRCWM, LAPS-IL057, LAPS-MN026, LAPS-OH007, MO036, TX190   
Study
CALGB-70305
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
N/A
Keywords: